Drugmaker Endo estimates profit above Street view; shares surge

(Reuters) - Endo International Plc on Monday gave a glimpse of a quarter that could help ease investor concerns when it announced preliminary earnings well above market estimates, sending the generic-drug maker's shares up as much as 18 percent.